NeoVista Receives $5,185,055 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8a167eb1-7152-4fcf-8ea2-e77e8b83d37e&Preview=1 - Date
5/14/2012 - Company Name
NeoVista - Mailing Address
38875 Cherry St. Newark, CA 94560 - Company Description
NeoVista, Inc. is developing a novel therapy to treat wet Age-Related Macular Degeneration (AMD) utilizing a Strontium-90 isotope. The delivery is made through a minimally invasive surgical procedure. The NeoVista, Inc. - Website
http://www.neovista-inc.com - Transaction Type
Venture Equity - Transaction Amount
$5,185,055 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
